Explore Watchlists Pricing

ACADIA PHARMACEUTICALS INC (ACAD) Balance sheet

Market cap

$3.6B

P/E ratio

9.2x

Summary Financials

Income statement Balance sheet Cash flow Other

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	7	58	12	62	102	164	69	135	190	326	147	115	189	320	178
Total cash & short-term investments	7	58	12	62	102	164	69	135	190	326	147	115	189	320	178
Accounts receivable, net	-	-	-	-	-	6	17	26	36	48	64	62	98	99	121
Inventories	-	-	-	-	-	4	5	4	6	10	-	-	-	-	-
Total current assets	32	109	188	325	219	548	373	526	760	718	618	508	616	938	1,062
Property, plant and equipment, net	0	0	1	1	2	3	3	3	3	9	8	6	5	4	8
Total assets	32	109	189	325	222	561	385	540	783	783	700	588	749	1,188	1,564
Accounts payable	2	1	0	2	2	4	9	3	7	8	7	13	18	16	11
Long-term debt, current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities	6	6	7	16	22	43	49	60	75	106	96	126	254	395	277
Total non-current liabilities	-	-	0	0	0	0	0	2	-	-	-	-	-	-	-
Total liabilities	9	6	7	16	22	43	49	61	84	156	159	187	317	455	337
Retained earnings	-347	-368	-406	-498	-663	-934	-1,224	-1,469	-1,704	-1,986	-2,154	-2,370	-2,431	-2,204	-1,813
Stockholders' equity	23	85	182	309	200	518	335	479	699	627	541	400	432	733	1,227
Working capital	-	-	-	-	-						-	-	-	-	-